EUTM file information

019092845

ASPEYA

October 16, 2024

Trademark Summary

The trademark application ASPEYA was filed by Vectura Fertin Pharma Switzerland S.A., a corporation established under the laws of the Swiss Confederation (the "Applicant"). Application under examination.

The application was filed in English (Spanish was selected as the second language).

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical products, nutraceuticals, vitamins and dietary supplements
    2. Pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions
    3. Pharmaceutical preparations for treatment of a wide variety of diseases and conditions in chewable form, in gum form, in lozenge form, and in pouch powder form
    4. Nicotine chewing gum
    5. Medicated cannabinoids.
  • The mark was filed in class 10 with following description of goods:
    1. Medical devices
    2. Medical devices for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals
    3. Inhalers
    4. Dry powder inhalers (DPI)
    5. Nebulizers
    6. Pressurized metered-dose inhalers (pMDI).
  • The mark was filed in class 32 with following description of goods:
    1. Non-alcoholic beverages
    2. Pastilles and powders for effervescing beverages
    3. Energy drinks
    4. Isotonic beverages
    5. Protein enriched sports beverages
    6. Whey beverages
    7. Syrups and other preparations for making non-alcoholic beverages.
  • The mark was filed in class 42 with following description of goods:
    1. Medical research services
    2. Scientific research services
    3. Pharmaceutical development services
    4. Formulation, research, and development of inhaled therapeutics
    5. Formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems.
  • The mark was filed in class 44 with following description of goods:
    1. Medical services
    2. Medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals
    3. Formulation, research, and development of inhaled therapeutics
    4. Formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems.